// App-Quantinova.ai

358.0 : Interim results of a multicenter phase ll trial of nab-paclitaxel (nab-P) plus gemcitabine (G) for patients (Pts) with locally advanced pancreatic cancer (LAPC).

Researchers

Presenter

  • Jill Lacy

Principal Investigators

  • Pascal Hammel

  • Roberto A. Pazo Cid

  • Jose Luis Manzano Mozo

  • Edward Jae-hoon Kim

  • Scot D. Dowden

  • Christophe Borg

  • Javier Sastre

  • Venu Gopal Bathini

  • Eric Terrebonne

  • Daniel Lopez-Trabada

  • Fernando Rivera

  • Jamil Asselah

  • Azzurra Damiani

  • Jimmy J. Hwang

  • Teng Jin Ong

  • Thom Nydam

  • Jack Shiansong Li

  • Philip Agop Philip

Medical Centers

  • Yale Cancer Center, New Haven, CT

  • Institut du Cancer de Montpellier, Montpellier, France

  • Hopital Beaujon, Clichy, France

  • Hospital Miguel Servet, Zaragoza, Spain

  • Hospital Universitari Germans Trias i Pujol, Badalona, Spain

  • UC Davis Comprehensive Cancer Center, Sacramento, CA

  • Tom Baker Cancer Center, Calgary, AB, Canada

  • Centre Hospitalier de Montelimar, Montelimar, France

  • Cancer Center of Excellence, University of Massachusetts Medical School, Worcester, MA

  • Hopital Haut Leveque, Giround, France

  • Hospital Saint Antoine, Paris, France

  • Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain

  • McGill University Royal Institution, Montreal, Quebec, Canada

  • IRCCS Azienda Ospedaliera Universitaria San Martino-IST, Genoa, Italy

  • Department of Medicine and Oncology and Innovation Center for Biomedical Informatics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC

  • Celgene Corporation, Summit, NJ

  • Karmanos Cancer Institute, Detroit, MI

Locations

  • United States

  • France

  • Spain

  • Canada

  • Italy

Companies

  • Celgene Corporation

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Gemcitabine

  • Paclitaxel

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • NCT02301143

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved